CRMD
CorMedix Inc
NASDAQ: CRMD · HEALTHCARE · BIOTECHNOLOGY
$7.48
-1.19% today
Updated 2026-04-29
Market cap
$586.55M
P/E ratio
3.64
P/S ratio
1.88x
EPS (TTM)
$2.04
Dividend yield
—
52W range
$6 – $17
Volume
1.3M
CorMedix Inc (CRMD) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+54.7%
Last 4 quarters
Revenue YoY growth
+312.1%
Most recent quarter
EPS YoY growth
-27.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+4.6%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+6.8%
2026-03-31
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-31 | $0.16 | -78.2% | $6.57 | $7.02 | +6.8% |
| 2025-10-28 | $1.41 | +529.6% | $11.05 | $11.31 | +2.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.74 | $0.16 | -78.2% | $128.62M | +312.1% |
| 2025-09-30 | $0.22 | $1.41 | +529.6% | $104.28M | +810.2% |
| 2025-06-30 | $0.16 | $0.28 | +75.0% | $39.74M | +4829.4% |
| 2025-03-31 | $0.25 | $0.30 | +22.2% | $39.08M | — |
| 2024-12-31 | $0.14 | $0.22 | +57.1% | $31.21M | +10162.7% |
| 2024-09-30 | $-0.10 | $-0.05 | +50.0% | $11.46M | — |
| 2024-06-30 | $-0.25 | $-0.25 | +0.0% | $806119.00 | — |
| 2024-03-31 | $-0.28 | $-0.25 | +10.7% | — | — |
| 2023-12-31 | $-0.20 | $-0.26 | -30.0% | $304110.00 | — |
| 2023-09-30 | $-0.21 | $-0.17 | +19.0% | — | — |
| 2023-06-30 | $-0.24 | $-0.25 | -4.2% | — | — |
| 2023-03-31 | $-0.20 | $-0.24 | -20.0% | — | — |
| 2022-12-31 | $-0.19 | $-0.20 | -5.3% | — | — |
Frequently asked questions
Has CorMedix Inc beaten earnings estimates?
CorMedix Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +54.7% over the last 4 quarters.
How does CRMD stock react to earnings?
CRMD stock has moved an average of +4.6% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is CorMedix Inc's revenue growth rate?
CorMedix Inc reported year-over-year revenue growth of +312.1% in its most recent quarter, with EPS growing -27.2% year-over-year.